TDOC Teladoc Health, Inc. Common Stock
Teladoc Health, Inc. Common Stock について Wikipediaからの企業概要
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
続きを読む
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.
History
2002–2015
Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.
Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.
2015–2016
Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.
In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.
In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.
2017–2020
In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.
On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.
Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.
In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.
2021–2024
In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.
On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.
Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.
In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.
In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.
2025–present
In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.
In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.
The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.
Services and business model
Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.
Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.
By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.
Disaster aid
Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.
Lobbying and legislation
Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.
In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.
In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
TDOC 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
TDOC 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
TDOC アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 4 12.9%
- 買い 7 22.6%
- 保有 20 64.5%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
19 アナリスト · 2026-08-14決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $-0.21 | $-0.25 | 0.04% |
| 2026年3月31日 | $-0.36 | $-0.32 | -0.04% |
| 2025年12月31日 | $-0.14 | $-0.19 | 0.05% |
| 2025年9月30日 | $-0.28 | $-0.27 | -0.01% |
| 2025年6月30日 | $-0.19 | $-0.27 | 0.08% |
| 2025年3月31日 | $-0.53 | $-0.34 | -0.19% |
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
| EVH | — | -0.8 | -26.6% | -28.5% | -81.5% | — |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
貸借対照表 28
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
キャッシュフロー 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
成長率 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM) 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
損益計算書 17
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
貸借対照表 25
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
キャッシュフロー 12
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
流動性と支払能力 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
バリュエーション(TTM) 9
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.50B | · | $2.53B | $2.54B | $2.56B | · | $2.59B | $2.60B | $2.59B | · | $2.55B | $2.49B | $2.40B | · | $2.29B | |
| Net Income TTM | $-185M | $-239M | · | $-208M | $-997M | $-1.05B | · | $-1.01B | $-1.04B | $-273M | · | $-265M | $-3.31B | $-9.92B | · | $-9.93B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.2 | -4.0 | · | -6.5 | -1.5 | -1.3 | · | -1.5 | -1.6 | -9.1 | · | -11.5 | -1.2 | -0.4 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.7 | 1.8 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| P / FCF | · | 125.2 | · | · | · | 105.8 | · | · | · | 329.0 | · | · | · | 393.4 | · | · | |
| Earnings Yield | -12.3% | -24.9% | · | -15.4% | -66.9% | -77.0% | · | -64.8% | -63.0% | -11.0% | · | -8.7% | -80.9% | -238.1% | · | -243.7% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| 営業利益率 % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| 純利益 | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| 希薄化後EPS | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | — | — | — | — | 0.0 |
| 流動比率 | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| クイックレシオ | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $285M | $283M | $339M | $173M | $185M |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家(13F) 398 提出者 · $1.2B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 73 (+11 前期比) | 33 (-40 前期比) | 104 (-10 前期比) | 88 (+3 前期比) | +36.3M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $139,930,938 | 19,990,134 | 11.50% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107,573,820 | 12,685,592 | 8.84% | 株式数 |
| Point72 Asset Management, L.P. | $69,874,581 | 8,239,927 | 5.74% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $68,457,700 | 8,072,842 | 5.63% | 株式数 |
| Voss Capital, LP | $68,235,838 | 8,046,679 | 5.61% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $67,458,671 | 7,955,032 | 5.55% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $59,415,442 | 7,006,538 | 4.88% | 株式数 |
| STATE STREET CORP | $42,080,999 | 4,962,382 | 3.46% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $41,505,394 | 4,894,504 | 3.41% | 株式数 |
| Allianz Asset Management GmbH | $39,572,734 | 4,666,596 | 3.25% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $33,651,520 | 3,967,415 | 2.77% | 株式数 |
| Monaco Asset Management SAM | $26,864,462 | 3,167,979 | 2.21% | 株式数 |
| JUPITER ASSET MANAGEMENT LTD | $26,370,375 | 3,109,714 | 2.17% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25,976,377 | 3,063,252 | 2.14% | 株式数 |
| GOLDMAN SACHS GROUP INC | $25,430,579 | 2,998,889 | 2.09% | 株式数 |
| Quantinno Capital Management LP | $23,904,416 | 2,818,917 | 1.97% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17,299,632 | 2,040,051 | 1.42% | 株式数 |
| AMERIPRISE FINANCIAL INC | $16,946,398 | 1,998,396 | 1.39% | 株式数 |
| Pale Fire Capital SE | $16,737,502 | 1,973,762 | 1.38% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16,435,088 | 1,938,100 | 1.35% | コールオプション |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,710,032 | 1,380,900 | 0.96% | プットオプション |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11,348,708 | 1,338,291 | 0.93% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $10,120,074 | 1,193,405 | 0.83% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $9,796,800 | 1,155,283 | 0.81% | 株式数 |
| Freestone Grove Partners LP | $7,338,160 | 865,349 | 0.60% | 株式数 |
| Man Group plc | $6,880,545 | 811,385 | 0.57% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $6,795,228 | 801,324 | 0.56% | 株式数 |
| CITADEL ADVISORS LLC | $6,795,024 | 801,300 | 0.56% | プットオプション |
| Union Square Park Capital Management, LLC | $6,784,000 | 800,000 | 0.56% | 株式数 |
| CITADEL ADVISORS LLC | $6,532,093 | 770,294 | 0.54% | 株式数 |
| FMR LLC | $6,418,334 | 756,879 | 0.53% | 株式数 |
| TCW GROUP INC | $6,248,039 | 736,797 | 0.51% | 株式数 |
| Voss Capital, LP | $5,936,000 | 700,000 | 0.49% | コールオプション |
| Empowered Funds, LLC | $5,764,619 | 679,790 | 0.47% | 株式数 |
| PEAK6 LLC | $5,227,920 | 616,500 | 0.43% | コールオプション |
| CITADEL ADVISORS LLC | $5,114,288 | 603,100 | 0.42% | コールオプション |
| Squarepoint Ops LLC | $5,089,696 | 600,200 | 0.42% | コールオプション |
| JANE STREET GROUP, LLC | $5,088,848 | 600,100 | 0.42% | プットオプション |
| FRANKLIN RESOURCES INC | $4,518,161 | 532,802 | 0.37% | 株式数 |
| TWO SIGMA ADVISERS, LP | $4,211,319 | 601,617 | 0.35% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3,700,706 | 436,404 | 0.30% | 株式数 |
| WOLVERINE TRADING, LLC | $3,607,180 | 439,900 | 0.30% | コールオプション |
| Parallax Volatility Advisers, L.P. | $3,392,000 | 400,000 | 0.28% | コールオプション |
| TUDOR INVESTMENT CORP ET AL | $3,288,603 | 387,807 | 0.27% | 株式数 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $3,248,866 | 383,121 | 0.27% | 株式数 |
| Swiss National Bank | $3,035,857 | 358,002 | 0.25% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $2,894,928 | 341,383 | 0.24% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $2,781,435 | 510,355 | 0.23% | 株式数 |
| Squarepoint Ops LLC | $2,761,936 | 325,700 | 0.23% | プットオプション |
| Trexquant Investment LP | $2,755,932 | 324,992 | 0.23% | 株式数 |
| D. E. Shaw & Co., Inc. | $2,544,000 | 300,000 | 0.21% | プットオプション |
| ORACLE INVESTMENT MANAGEMENT INC | $2,480,366 | 354,338 | 0.20% | 株式数 |
| Soviero Asset Management, LP | $2,442,240 | 288,000 | 0.20% | コールオプション |
| D. E. Shaw & Co., Inc. | $2,371,941 | 279,710 | 0.20% | 株式数 |
| BlackRock, Inc. | $2,312,106 | 272,654 | 0.19% | 株式数 |
| IEQ CAPITAL, LLC | $2,273,165 | 268,062 | 0.19% | 株式数 |
| JANE STREET GROUP, LLC | $2,155,616 | 254,200 | 0.18% | コールオプション |
| WOLVERINE TRADING, LLC | $2,059,020 | 251,100 | 0.17% | プットオプション |
| RHUMBLINE ADVISERS | $2,058,803 | 242,785 | 0.17% | 株式数 |
| Walleye Trading LLC | $2,017,188 | 237,876 | 0.17% | 株式数 |
| WINTON GROUP Ltd | $1,925,808 | 227,100 | 0.16% | 株式数 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1,906,796 | 224,858 | 0.16% | 株式数 |
| Brevan Howard Capital Management LP | $1,880,084 | 221,708 | 0.15% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1,704,675 | 243,525 | 0.14% | 株式数 |
| UBS Group AG | $1,696,000 | 200,000 | 0.14% | コールオプション |
| NOMURA HOLDINGS INC | $1,696,000 | 200,000 | 0.14% | プットオプション |
| Parker Investment Management, LLC | $1,586,515 | 187,089 | 0.13% | 株式数 |
| OPPENHEIMER & CO INC | $1,571,268 | 185,291 | 0.13% | 株式数 |
| ABS Direct Equity Fund LLC | $1,513,154 | 178,438 | 0.12% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,495,703 | 274,441 | 0.12% | 株式数 |
| Summit Trail Advisors, LLC | $1,488,766 | 175,562 | 0.12% | 株式数 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $1,484,000 | 175,000 | 0.12% | 株式数 |
| SIMPLEX TRADING, LLC | $1,396,808 | 164,718 | 0.11% | 株式数 |
| BARCLAYS PLC | $1,347,861 | 158,946 | 0.11% | 株式数 |
| NATIXIS | $1,347,472 | 158,900 | 0.11% | 株式数 |
| WELLS FARGO & COMPANY/MN | $1,346,183 | 158,748 | 0.11% | 株式数 |
| JENNISON ASSOCIATES LLC | $1,333,793 | 157,287 | 0.11% | 株式数 |
| Rock Creek Group LLC | $1,329,944 | 156,833 | 0.11% | 株式数 |
| MACKENZIE FINANCIAL CORP | $1,297,381 | 152,993 | 0.11% | 株式数 |
| Walleye Trading LLC | $1,277,936 | 150,700 | 0.11% | プットオプション |
| Counterpoint Mutual Funds LLC | $1,252,301 | 147,677 | 0.10% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $1,233,111 | 145,414 | 0.10% | 株式数 |
| Balyasny Asset Management L.P. | $1,226,208 | 144,600 | 0.10% | プットオプション |
| TWO SIGMA INVESTMENTS, LP | $1,217,245 | 143,543 | 0.10% | 株式数 |
| ALGERT GLOBAL LLC | $1,211,792 | 142,900 | 0.10% | 株式数 |
| Engineers Gate Manager LP | $1,204,499 | 142,040 | 0.10% | 株式数 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,187,666 | 140,055 | 0.10% | 株式数 |
| Walleye Capital LLC | $1,082,896 | 127,700 | 0.09% | コールオプション |
| Leonteq Securities AG | $1,064,384 | 125,517 | 0.09% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,045,813 | 123,327 | 0.09% | 株式数 |
| JANUS HENDERSON GROUP PLC | $1,038,988 | 190,640 | 0.09% | 株式数 |
| Walleye Capital LLC | $989,616 | 116,700 | 0.08% | プットオプション |
| Crawford Fund Management, LLC | $987,072 | 116,400 | 0.08% | プットオプション |
| OP Asset Management Ltd | $958,969 | 113,086 | 0.08% | 株式数 |
| Vanguard Global Advisers, LLC | $932,469 | 109,961 | 0.08% | 株式数 |
| CHIRON CAPITAL MANAGEMENT, LLC | $930,850 | 109,770 | 0.08% | 株式数 |
| Jefferies Financial Group Inc. | $907,657 | 107,035 | 0.07% | 株式数 |
| MetLife Investment Management, LLC | $901,746 | 106,338 | 0.07% | 株式数 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $891,845 | 96,104 | 0.07% | 株式数 |
| Y-Intercept (Hong Kong) Ltd | $876,815 | 103,398 | 0.07% | 株式数 |
企業インサイダー 48 人のインサイダー · 23人の役員 · 22人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 2026年6月10日 M | 414,622 | 0 | 6 | $-938,572 |
| Jason N Gorevic | Chief Executive Officer | 2022年3月4日 M | 516,464 | 0 | 0 | $0 |
| Mala Murthy | Chief Financial Officer | 2022年3月1日 A | 17,357 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 2018年12月13日 M | 10,000 | 0 | 0 | $0 |
| Kelly Bliss | President, U.S. Group Health | 2026年7月6日 S | 84,878 | 0 | 4 | $-126,068 |
| Fernando M. Rodrigues | President of BetterHelp | 2026年6月3日 S | 0 | 0 | 2 | $-114,131 |
| Carlos Nueno | President, International | 2026年6月1日 M | 57,671 | 0 | 1 | $-47,257 |
| Peter A Mcclennen | President | 2019年7月15日 M | 0 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 2021年7月29日 M | 11,031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 2026年7月1日 M | 12,267 | 0 | 2 | $-8,108 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 2026年6月1日 M | 110,261 | 0 | 3 | $-241,831 |
| Daniel Trencher | SVP Corporate Strategy | 2022年3月4日 M | 29,408 | 0 | 0 | $0 |
| Stephany Verstraete | Chief Marketing Officer | 2022年3月4日 M | 31,828 | 0 | 0 | $0 |
| Andrew Turitz | SVP - Business Development | 2022年3月4日 M | 14,794 | 0 | 0 | $0 |
| Claus Torp Jensen | Chief Innovation Officer | 2022年3月1日 A | — | 0 | 0 | $0 |
| Arnnon Geshuri | Chief Human Resources Officer | 2022年3月1日 A | 83,168 | 0 | 0 | $0 |
| Richard J Napolitano | Chief Accounting Officer | 2022年3月1日 A | 1,195 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 2020年10月1日 M | 8,766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 2020年9月1日 M | 3,232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 2020年7月1日 A | — | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 2020年4月16日 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 2017年5月25日 A | 61,459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 2017年3月13日 A | — | 0 | 0 | $0 |
| Mark V Anquillare | 取締役 | 2026年8月3日 A | — | 0 | 0 | $0 |
| David B Snow JR | 取締役 | 2026年5月21日 A | 113,032 | 0 | 0 | $0 |
| David L Shedlarz | 取締役 | 2026年5月21日 A | 61,266 | 0 | 0 | $0 |
| Susan R Salka | 取締役 | 2026年3月30日 A | — | 0 | 0 | $0 |
| Catherine Jacobson | 取締役 | 2022年2月18日 M | 1,468 | 0 | 0 | $0 |
| William H. Frist | 取締役 | 2021年9月15日 M | 12,918 | 0 | 0 | $0 |
| Karen L Daniel | 取締役 | 2021年8月25日 M | 41,915 | 0 | 0 | $0 |
| Christopher Bischoff | 取締役 | 2021年5月25日 M | 5,121 | 0 | 0 | $0 |
| Mark Douglas Smith | 取締役 | 2021年5月17日 A | 3,536 | 0 | 0 | $0 |
| Kenneth H Paulus | 取締役 | 2021年5月17日 A | 0 | 0 | 0 | $0 |
| Thomas Mckinley | 取締役 | 2021年5月17日 A | 5,879 | 0 | 0 | $0 |
| Hemant Taneja | 取締役 | 2021年4月19日 S | 118,760 | 0 | 0 | $0 |
| Glen Tullman | 取締役 | 2021年4月1日 M | 275,793 | 0 | 0 | $0 |
| Helen Darling | 取締役 | 2020年6月11日 M | 918 | 0 | 0 | $0 |
| Arneek Multani | 取締役 | 2019年5月30日 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | 取締役 | 2019年5月30日 A | 1,965 | 0 | 0 | $0 |
| Tom Mawhinney | 取締役 | 2018年5月25日 M | 46,203 | 0 | 0 | $0 |
| Martin R Felsenthal | 取締役 | 2016年8月8日 A | 10,860 | 0 | 0 | $0 |
| Dana G Mead Jr. | 取締役 | 2016年8月8日 A | 202 | 0 | 0 | $0 |
| James K Outland | 取締役 | 2015年7月13日 M | 49,986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | 10%オーナー | 2017年4月26日 J | 2,480,468 | 0 | 0 | $0 |
| CHP III LP | 10%オーナー | 2017年4月26日 J | 2,480,468 | 0 | 0 | $0 |
| Sandra L Fenwick | — | 2026年5月21日 A | 10,762 | 0 | 0 | $0 |
| Yulun Wang | — | 2021年1月25日 S | 219,507 | 0 | 0 | $0 |
| Michael Goldstein | — | 2020年6月11日 M | 0 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 2保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 提出書類 | 2021年4月15日 | — | 初回提出 | — | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 提出書類 | 2021年3月16日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 55のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| HEAL · Global X Funds | 1.18% | 38,782 NS | 2026年5月31日 | N-PORT |
| SVAL · iShares Trust | 0.42% | 129,925 SH | 2026年8月8日 | 日次 |
| JSML · Janus Detroit Street Trust | 0.34% | 178,607 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.20% | 261,035 NS | 2026年5月31日 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.18% | 66,764 NS | 2026年5月31日 | N-PORT |
| IHF · iShares Trust | 0.18% | 332,174 SH | 2026年8月8日 | 日次 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.10% | 159,976 SH | 2026年8月8日 | 日次 |
| SMLF · iShares Trust | 0.09% | 592,154 SH | 2026年8月8日 | 日次 |
| FNDA · SCHWAB STRATEGIC TRUST | 0.08% | 978,669 NS | 2026年5月31日 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0.08% | 2,910,344 NS | 2026年5月31日 | N-PORT |
| IWN · iShares Trust | 0.08% | 1,690,654 SH | 2026年8月8日 | 日次 |
| GINN · Goldman Sachs ETF Trust | 0.08% | 21,242 NS | 2026年5月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.07% | 920,742 NS | 2026年4月30日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.07% | 155,542 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.07% | 252,145 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.06% | 67,673 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.05% | 1,047,849 SH | 2026年8月8日 | 日次 |
| VFMF · VANGUARD WELLINGTON FUND | 0.04% | 29,737 SH | 2026年8月8日 | 日次 |
| IWM · iShares Trust | 0.04% | 4,666,989 SH | 2026年8月8日 | 日次 |
| ISCV · iShares Trust | 0.04% | 38,629 SH | 2026年8月8日 | 日次 |
| PNQI · Invesco Exchange-Traded Fund Trust | 0.04% | 26,986 SH | 2026年8月8日 | 日次 |
| ITWO · ProShares Trust | 0.03% | 8,377 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.03% | 77,120 NS | 2026年4月30日 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.03% | 2,631,374 SH | 2026年8月8日 | 日次 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 858,463 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 584,184 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 2,084,219 SH | 2026年8月8日 | 日次 |
| VB · VANGUARD INDEX FUNDS | 0.02% | 4,153,113 SH | 2026年8月8日 | 日次 |
| UWM · ProShares Trust | 0.02% | 6,552 NS | 2026年5月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.02% | 535,056 SH | 2026年8月8日 | 日次 |
| ISCB · iShares Trust | 0.02% | 7,717 SH | 2026年8月8日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 81,058 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.02% | 10,585 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 6,629 NS | 2026年5月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.01% | 285,019 NS | 2026年4月30日 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.01% | 170,044 SH | 2026年8月8日 | 日次 |
| WSML · iShares Trust | 0.01% | 10,387 SH | 2026年8月8日 | 日次 |
| TILT · FlexShares Trust | 0.01% | 34,034 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 6,863 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 166 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 422,235 NS | 2026年4月30日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.01% | 9,970 NS | 2026年5月31日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.01% | 1,783 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 22,871 NS | 2026年4月30日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 11,743 NS | 2026年4月30日 | N-PORT |
| DSI · iShares Trust | 0.00% | 25,216 SH | 2026年8月8日 | 日次 |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 42,456 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 105,579 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 232,888 SH | 2026年8月8日 | 日次 |
| IWV · iShares Trust | 0.00% | 45,271 SH | 2026年8月8日 | 日次 |